maestro, allow me to offer a personal opinion, March will be 'calling the game too late*', there is little wrong here, sentiment is playing the main part in holding the SP back, or put another way... mistrust.
Wong has clearly identified the issues and from what we can read is addressing them as fast as he and his team can, look around you, competitive forces are everywhere,whatever product you are in, so to compete, they have cut costs by almost 2 million, improved the product offering, will (imo) have a top line of between of 35 and 40 million, with a contribution of around 25 to 28% due to the the vastly improved productivity and have they also have sufficient cash resources.....forget all those silly scare stories about Headstart.
Second half sales of 16 million against 14 million for the first half.
This is not a weak attempt at ramping, but I 100% believe that Medisys will in investment terms prove to be a star of 2006
Making such a statement, I know that I am open to ridicule, but I have broad shoulders.
I will buy again!!!
imo/dyor